Quality of life and polysensitization in young men with intermittent asthma

Annals of Allergy, Asthma and Immunology

Volumn 94, Issue 6, 2005, Pages 640-643

  Cirillo, Ignazio ^a   Vizzaccaro, Andrea ^a   Klersy, Catherine ^b   Baiardini, Ilaria ^c   Marseglia, Gian Luigi ^b   Canonica, G Walter ^c   Tosca, Maria Angela ^d   Ciprandi, Giorgio ^e  

^a Ospedale Marina Militare   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHACHOLINE;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIZATION; SPIROMETRY;

EID: 20544461603     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61321-X     Document Type: Article

References (15)

1. Van Cauwenberg P. Advances in allergy management. Allergy. 2002;57:29-36.
2. Gerth van Wijk R. Allergy: a global problem: quality of life. Allergy. 2002;57:1097-1110.
3. Orr LC, Fowler SJ, Lipworth BJ. Relationship between changes in quality of life of lung function and bronchial hyperresponsiveness during high-dose inhaled corticosteroid treatment. Am J Respir Med. 2003;2:433-438.
4. Riccioni G, D'Orazio N, Di Ilio C, et al. Bronchial hyperresponsiveness and quality of life in asthmatics. Respiration. 2003;70:496-499.
5. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147:832-838.
6. Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 1997. NIH publication 96-3659B.
7. EAACI Subcommittee on Skin Tests. Skin tests used in type I allergy testing. Allergy. 1989;44(suppl 10):22-31.
8. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Standardized lung function testing. Eur Respir J. 1993;6:1-99.
9. Ciprandi G, Cirillo I, Tosca MA, Vizzaccaro A. Bronchial hyperreactivity and spirometric impairment in patients with seasonal allergic rhinitis. Respir Med. 2004;98:826-831.
10. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease specific quality of life questionnaire. J Clin Epidemiol. 1994;47:81-87.
11. Blaiss MS. Outcomes analysis in asthma. JAMA. 1997;278: 1874-1880.
12. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trial. Thorax. 1992;47:76-83.
13. Ciprandi G, Vizzaccaro A, Cirillo A, Tosca MA, Passalacqua G, Canonica GW. Underdiagnosis and undertreatment of asthma: a nine-year study on Italian conscripts. Int Arch Allergy Immunol. 2001;125:211-215.
14. Ciprandi G, Buscaglia S, Pesce GP, et al. Minimal persistent inflammation is present at mucosal level in asymptomatic rhinitic patients with allergy due to mites. J Allergy Clin Immunol. 1995;96:971-979.
15. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponisveness in allergic asthma. Am J Respir Crit Care Med. 1998;157:4-9.